Bank of America
TMCI icon

Bank of America’s Treace Medical Concepts TMCI Stock Holding History

Bank of America’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.2M Buy
3,305,100
+90,807
+3% +$250K ﹤0.01% 2833
2026
Q1 		$4.31M Buy
3,214,293
+900,071
+39% +$1.79M ﹤0.01% 3586
2025
Q4 		$5.67M Buy
2,314,222
+2,228,317
+2,594% +$9.68M ﹤0.01% 3286
2025
Q3 		$576K Buy
85,905
+13,332
+18% +$87K ﹤0.01% 5702
2025
Q2 		$427K Buy
72,573
+25,130
+53% +$164K ﹤0.01% 5798
2025
Q1 		$398K Sell
47,443
-96,625
-67% -$868K ﹤0.01% 5780
2024
Q4 		$1.07M Buy
144,068
+59,848
+71% +$400K ﹤0.01% 4972
2024
Q3 		$488K Sell
84,220
-63,665
-43% -$409K ﹤0.01% 5496
2024
Q2 		$983K Buy
147,885
+35,182
+31% +$284K ﹤0.01% 4917
2024
Q1 		$1.47M Sell
112,703
-8,254
-7% -$110K ﹤0.01% 4658
2023
Q4 		$1.54M Buy
120,957
+39,523
+49% +$399K ﹤0.01% 4627
2023
Q3 		$1.07M Buy
81,434
+22,283
+38% +$408K ﹤0.01% 4774
2023
Q2 		$1.51M Sell
59,151
-33,786
-36% -$872K ﹤0.01% 4455
2023
Q1 		$2.34M Sell
92,937
-163,074
-64% -$3.83M ﹤0.01% 4217
2022
Q4 		$5.89M Buy
256,011
+188,211
+278% +$4.33M ﹤0.01% 3243
2022
Q3 		$1.5M Buy
67,800
+8,797
+15% +$170K ﹤0.01% 4544
2022
Q2 		$846K Sell
59,003
-1,715
-3% -$28.9K ﹤0.01% 5051
2022
Q1 		$1.15M Buy
60,718
+44,204
+268% +$859K ﹤0.01% 5100
2021
Q4 		$308K Buy
16,514
+15,536
+1,589% +$321K ﹤0.01% 6224
2021
Q3 		$26K Buy
978
+784
+404% +$21.6K ﹤0.01% 7316
2021
Q2 		$6K Buy
+194
New +$6.17K ﹤0.01% 7405

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Bank of America's TMCI Position: Q2 2026 in Review

Bank of America increased its Treace Medical Concepts (TMCI) stake by 2.8% in Q2 2026, buying an estimated $250K and bringing the position to 3,305,100 shares worth $13.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2833.

Bank of America first reported a position in TMCI in Q2 2021 and has held it in 21 quarters since. 116 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Bank of America held 3,305,100 shares of Treace Medical Concepts worth $13.2M as of Q2 2026.
  • Bank of America bought 90,807 Treace Medical Concepts shares in Q2 2026, an estimated $250K.
  • Treace Medical Concepts made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #2833 holding.
  • Bank of America first reported a position in Treace Medical Concepts in Q2 2021 and has held it in 21 quarters since.
  • 116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.